Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer Treatment
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- Rigshospitalet, Denmark
- Enrollment
- 2411
- Locations
- 1
- Primary Endpoint
- Prevalence of persistent pain
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
Persistent pain, sensory disturbances, lymphedema and functional impairment are frequently occurring late effects of breast cancer treatment. The investigators have previously published data on 3253 women treated for breast cancer in Denmark in the period 2005-2006. Very few studies have examined how these late effects change in time. The aim of this study is to examine in a well defined patient population any change in the prevalence of persistent pain, sensory disturbances, lymphedema and functional impairment, as well as risk factor profile.
Investigators
Kenneth Geving Andersen
MD
Rigshospitalet, Denmark
Eligibility Criteria
Inclusion Criteria
- •Diagnosed with primary breast cancer between 2005-2006
- •Participated in a study in 2008
Exclusion Criteria
- •Recurrent or new primary cancer
- •Metastatic cancer
- •Reconstructive surgery
Outcomes
Primary Outcomes
Prevalence of persistent pain
Time Frame: 6-7 years post operative
Prevalence of pain in the breast area, axilla, side of chest or arm, as a yes/no variable
Prevalence of patients changing pain status from the 2008 survey
Time Frame: 6-7 years
Secondary Outcomes
- Prevalence of sensory disturbance(6-7 years)
- Prevalence of self reported lymphedma(6-7 years)
- Prevalence of functional impairment(6-7 years)
- Risk factors associated for persistent pain, sensory disturbances, lymphedema or functional impairment(6-7 years)
- Prevalence of patients changing status of sensory disturbances and self reported lymphedma(6-7 years)
- Risk factors associated to changing status of sensory disturbances and lymphedema(6-7 years post operative)